Innovating Works
HORIZON-HLTH-2021-CARE-05-02
HORIZON-HLTH-2021-CARE-05-02: Data-driven decision-support tools for better health care delivery and policy-making with a focus on cancer
ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 4 “Ensuring access to innovative, sustainable and high-quality health care”. To that end, proposals under this topic should aim for delivering results that are directed at, tailored towards and contributing to some of the following expected outcomes:
Sólo fondo perdido 0 €
European
This call is closed Esta línea ya está cerrada por lo que no puedes aplicar.
An upcoming call for this aid is expected, the exact start date of call is not yet clear.
Presentation: Consortium Consortium: Esta ayuda está diseñada para aplicar a ella en formato consorcio.
Minimum number of participants.
This aid finances Proyectos:

ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 4 “Ensuring access to innovative, sustainable and high-quality health care”. To that end, proposals under this topic should aim for delivering results that are directed at, tailored towards and contributing to some of the following expected outcomes:

Health care organisations and policymakers adopt robust and transparent modelling (including data collection, storage and analysis), planning algorithms and artificial intelligence (AI) solutions in support of health care decision-making processes; Health care providers, caregivers (formal and informal), citizens, and other relevant stakeholders take better informed decisions about their health or the health of persons they are responsible for and/or about the organisation of the health care service or system they are involved in or in charge of;Health system owners are provided with evidence-based participative decision-making processes that take into consideration all relevant values, needs and perspectives, enabling to deliver health care services to patients in the most suitable a... see more

ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 4 “Ensuring access to innovative, sustainable and high-quality health care”. To that end, proposals under this topic should aim for delivering results that are directed at, tailored towards and contributing to some of the following expected outcomes:

Health care organisations and policymakers adopt robust and transparent modelling (including data collection, storage and analysis), planning algorithms and artificial intelligence (AI) solutions in support of health care decision-making processes; Health care providers, caregivers (formal and informal), citizens, and other relevant stakeholders take better informed decisions about their health or the health of persons they are responsible for and/or about the organisation of the health care service or system they are involved in or in charge of;Health system owners are provided with evidence-based participative decision-making processes that take into consideration all relevant values, needs and perspectives, enabling to deliver health care services to patients in the most suitable and efficient manner;Policymakers access evidence-based, interoperable decision support tools for public health policy-making and health care delivery.
Scope:This call topic will contribute to Europe’s Beating Cancer Plan activities[1] and other relevant initiatives such as the European Cancer Information System[2]. For this reason, proposals must focus on one or more phases of the cycle of the disease, starting from prevention and early diagnosis to treatment and quality of life of patients and survivors.

An ever-increasing amount of data is at the disposal of decision- and policy-makers, which, if analysed, pooled and used, could lead to novel data-driven approaches in health care delivery and policy-making, thus improving quality of life, health equity and producing better health outcomes. The collection, access, processing, and (primary and secondary) use of data is still very fragmented across national health systems. The availability and use of structured and unstructured health data represents an opportunity for the implementation of data-driven innovation and it provides new opportunities for developing, monitoring and evaluating decisions, and providing feedback into decision-making processes and policy strategies.

In this topic, research and innovation actions should aim at optimising and/or transforming health care delivery decision-making processes, supporting policy-making, and/or empowering citizens and cancer patients. The development of innovations, including tools, processes and services, should be done together with end-users (i.e. citizens, health professionals and policymakers), and represent both a support-base and scientific evidence for data-driven innovation. Design thinking and other relevant design methodologies should be considered.

The proposals should adhere to the FAIR data[3] principles and adopt data quality standards, data integration operating procedures and GDPR-compliant data sharing/access best practices developed by the European research infrastructures, if relevant. In addition, the proposals are encouraged to adopt best practices of international standards used in the development of computational models.

Data-driven algorithms should be explainable, unbiased and inclusive. Caution needs to be paid to systematically control for gender and racial bias and/or discrimination bias, when developing and using data and algorithms. The actions should ensure that the novel ideas are accompanied by frameworks/guidelines for new forms of collaboration and incentivising mechanisms/tools in order to support implementation of the innovations in the public sector. The tools should aim to improve health outcomes and quality of life, not only to lower health care costs.

Actions should pursue a multi-disciplinary and multi-stakeholder approach to integrate health care research, health services research, innovation, health economics, implementation science, operations management/research, data science and other relevant disciplines (i.e. sociology and anthropology) to ensure more equitable, innovative and sustainable health care systems.

Applicants should propose activities underpinned by health care data in one or more of the following areas:

The development of data-driven, interactive policy and visualisation tools (i.e. through creation of digital twins/virtual models) bringing novel insights on populations, systems and services as a whole, to help policymakers make data-driven decisions. These can be foreseen to be used solely for health care decisions or constitute health-relevant inputs for other sectorial approaches, and promote multi-disciplinary knowledge exchange;The development of data-driven solutions (i.e scenario-building tools and models) helping health care organisations take evidence-informed decisions on cancer care delivery processes such as logistics planning and management, capacity, utilisation of health services and allocation of resources and infrastructures (i.e. human resources, health goods, etc.), and availability of and access to health care technologies (i.e. pharmaceuticals, vaccines, medical devices, etc.) and interventions;The development of data-driven solutions empowering citizens' and cancer patients' interaction with the health care systems, including feedback mechanisms, guidance on health care pathways and on managing health care data, supporting patients in making health care decisions and treatment adherence; The development of digital toolkits and indicators to improve the reporting and assessment of outputs from end-user involvements, including those of patient-reported outcomes measures (PROMs) and patient-reported experience measures (PREMs), and help gauge the actual impact in health care (including interaction between patients and health care providers). Applicants are encouraged to establish dynamic relations and synergies with the following areas, where applicable:

Decision-making processes and tools, including social innovation;Monitoring and evaluating the budgetary impact of health care interventions (i.e. innovative solutions, digital services and health care models);Health technology assessment and cost-effectiveness analysis;Artificial intelligence/deep learning tools in social medicine to determine causal factors of disease/conditions and develop interventions;Data sharing between different institutions;European Health Data Space (EHDS);Open source and/or common building blocks used in Connecting Europe Facility (CEF) (e.g. eDelivery, eID);Standards and mechanisms to allow for interoperability between primary and secondary use of data;Privacy-preserving protocols for secondary use of data for public health policy-making and research;Federated/distributed access or data processing protocols for data-driven decision-support tools for better health care delivery and policy-making. Proposals should adopt a patient-centred approach that empowers patients, promotes a culture of dialogue and openness between citizens/patients, caregivers, health care providers and other relevant stakeholders, and unleashes the potential for social innovation.

Whenever the data sources proposed to be used by the applicants include genomics data, the proposals should consider the data standards and legal, ethical and technical interoperability requirements and guidelines agreed under the 1+ Million Genomes Initiative[4] where relevant.

If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).


Cross-cutting Priorities:Socio-economic science and humanitiesEOSC and FAIR dataSocial Innovation


[1]https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/12154-Europe-s-Beating-Cancer-Plan

[2]European Cancer Information System https://ecis.jrc.ec.europa.eu/

[3]FAIR data are data, which meet principles of findability, accessibility, interoperability, and reusability.

[4]https://digital-strategy.ec.europa.eu/en/policies/1-million-genomes



see less

Temáticas Obligatorias del proyecto: Temática principal: Foresight Oncology EOSC and FAIR data Social Innovation Social sciences and humanities Health care sciences and services (including hospi Computer sciences information science and bioinfo

Consortium characteristics

Scope European : The aid is European, you can apply to this line any company that is part of the European Community.
Tipo y tamaño de organizaciones: The necessary consortium design for the processing of this aid needs:

characteristics of the Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 4 “Ensuring access to innovative, sustainable and high-quality health care”. To that end, proposals under this topic should aim for delivering results that are directed at, tailored towards and contributing to some of the following expected outcomes: ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 4 “Ensuring access to innovative, sustainable and high-quality health care”. To that end, proposals under this topic should aim for delivering results that are directed at, tailored towards and contributing to some of the following expected outcomes:
Do you want examples? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Financial Chapters: The chapters of financing expenses for this line are:
Personnel costs.
Expenses related to personnel working directly on the project are based on actual hours spent, based on company costs, and fixed ratios for certain employees, such as the company's owners.
Subcontracting costs.
Payments to external third parties to perform specific tasks that cannot be performed by the project beneficiaries.
Purchase costs.
They include the acquisition of equipment, amortization, material, licenses or other goods and services necessary for the execution of the project
Other cost categories.
Miscellaneous expenses such as financial costs, audit certificates or participation in events not covered by other categories
Indirect costs.
Overhead costs not directly assignable to the project (such as electricity, rent, or office space), calculated as a fixed 25% of eligible direct costs (excluding subcontracting).
Madurez tecnológica: The processing of this aid requires a minimum technological level in the project of TRL 4:. Los componentes que integran determinado proyecto de innovación han sido identificados y se busca establecer si dichos componentes individuales cuentan con las capacidades para actuar de manera integrada, funcionando conjuntamente en un sistema. + info.
TRL esperado:

Characteristics of financing

Intensidad de la ayuda: Sólo fondo perdido + info
Lost Fund:
0% 25% 50% 75% 100%
For the eligible budget, the intensity of the aid in the form of a lost fund may reach as minimum a 100%.
The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations. The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations.
Guarantees:
does not require guarantees
No existen condiciones financieras para el beneficiario.

Additional information about the call

incentive effect: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
non -competitive competitive Very competitive
We do not know the total budget of the line
minimis: Esta línea de financiación NO considera una “ayuda de minimis”. You can consult the regulations here.

other advantages

SME seal: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
HORIZON-HLTH-2021-CARE-05 Data-driven decision-support tools for better health care delivery and policy-making with a focus on cancer ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination...
Sin info.
HORIZON-HLTH-2021-CARE-05-02 Health care innovation procurement network
en consorcio:
Cerrada does 6 months | next call scheduled for the month of
HORIZON-HLTH-2021-CARE-05-02 European partnership on transforming health and care systems
Cerrada does 6 months | next call scheduled for the month of
HORIZON-HLTH-2021-CARE-05-02 Enhancing quality of care and patient safety
en consorcio: ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination...
Cerrada does 8 months | next call scheduled for the month of
HORIZON-HLTH-2021-CARE-05-02 European partnership on transforming health and care systems
en consorcio:
Cerrada does 8 months | next call scheduled for the month of
HORIZON-HLTH-2021-CARE-05-02 Health care innovation procurement network
en consorcio:
Cerrada does 8 months | next call scheduled for the month of